<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00844701</url>
  </required_header>
  <id_info>
    <org_study_id>BOLD fMRI</org_study_id>
    <nct_id>NCT00844701</nct_id>
  </id_info>
  <brief_title>Cue Induced Imaging in Nicotine Dependent Smokers</brief_title>
  <official_title>Validation of Cue Induced Imaging Paradigm in Nicotine Dependent Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the relationship between craving to smoke and areas&#xD;
      activated in brain. The researchers are using functional magnetic resonance imaging (MRI)&#xD;
      that measures brain blood flow, or perfusion, to study this brain activation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Functional magnetic resonance imaging has demonstrated that the same types of environmental&#xD;
      cues that induce craving activate an integrated network of brain areas involved in the&#xD;
      appetitive and motivational process of addiction to drugs of abuse including nicotine (&#xD;
      Brieter 119; Koob 2001, Volkow 2003).In nicotine deprived smokers both mesolimbic dopamine&#xD;
      reward pathways (amygdala, ventral tegmental area, and medial thalamus) and areas related to&#xD;
      visuospatial attention (bilateral prefrontal cortex and parietal cortex and right fusiform&#xD;
      gyrus) are activated by exposure to smoking images (Due 2002, David 2005).&#xD;
&#xD;
      In line with the National Institute on Drug Abuse's (NIDA) emphasis on novel methods for&#xD;
      investigating substance use disorders, the current study proposes to use fMRI to better&#xD;
      understand the neurological correlates of cue reactivity among nicotine dependent smokers.&#xD;
      This approach will permit the isolation of pathways that are relevant to cue induced craving.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">52</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>Non-smoker</arm_group_label>
    <description>Non-smoking control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nicotine Dependent Smoking Group</arm_group_label>
    <description>current smokers</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        adult nicotine dependent smokers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (nicotine dependent smoking group):&#xD;
&#xD;
          1. Age 18 - 60.&#xD;
&#xD;
          2. Participants will meet criteria for primary nicotine dependence, smoke at least 70% of&#xD;
             days in the last 30 days prior to assessment.&#xD;
&#xD;
          3. Able to read and understand questionnaires and informed consent.&#xD;
&#xD;
          4. Right-handed.&#xD;
&#xD;
          5. Currently is not engaged in, and does not want, treatment for nicotine related&#xD;
             problems.&#xD;
&#xD;
          6. Able to maintain abstinence from nicotine during the study period.&#xD;
&#xD;
          7. Participants must have a negative rapid-screening UDS and pregnancy test prior to&#xD;
             imaging session.&#xD;
&#xD;
        Inclusion Criteria (nonsmoking control group):&#xD;
&#xD;
          1. Age 18 - 60.&#xD;
&#xD;
          2. Does not meet the DSM-IV criterion for lifetime or current substance dependence.&#xD;
&#xD;
          3. Has used tobacco products no more than on experimental basis (none in past year).&#xD;
&#xD;
          4. Participants must have a negative rapid-screening UDS and pregnancy test prior to&#xD;
             session.&#xD;
&#xD;
          5. Righthanded.&#xD;
&#xD;
        Exclusion Criteria (all participants):&#xD;
&#xD;
          1. Currently meets DSM-IV criteria for any other psychoactive substance dependence&#xD;
             disorder except nicotine dependence.&#xD;
&#xD;
          2. Any psychoactive substance abuse within the last 30 days as evidenced by subject&#xD;
             report or urine drug screen.&#xD;
&#xD;
          3. Meets DSM-IV criteria for current axis I disorders of major depression, panic&#xD;
             disorder, obsessive compulsive disorder, post-traumatic stress syndrome, bipolar&#xD;
             affective disorder, schizophrenia, or any other psychotic disorder or organic mental&#xD;
             disorder. The rationale for excluding them is that symptoms from these disorders may&#xD;
             affect dependent variables and complicate interpretation of the data.&#xD;
&#xD;
          4. Has current suicidal ideation with plan or homicidal ideation.&#xD;
&#xD;
          5. Need for maintenance or acute treatment with any psychoactive medication including&#xD;
             antiseizure medications.&#xD;
&#xD;
          6. Clinically significant medical problems such as cardiovascular, renal, GI, or&#xD;
             endocrine problem that would impair participation or limit ability to participate in&#xD;
             scan.&#xD;
&#xD;
          7. Sexually active females of child-bearing potential who are pregnant (by urine HCG),&#xD;
             nursing, or who are not using a reliable form of birth control.&#xD;
&#xD;
          8. Has current charges pending for a violent crime (not including DUI related offenses).&#xD;
&#xD;
          9. Persons with ferrous metal implants or pacemaker since fMRI will be used.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Hartwell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Universtiy of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <study_first_submitted>February 12, 2009</study_first_submitted>
  <study_first_submitted_qc>February 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2009</study_first_posted>
  <last_update_submitted>October 31, 2012</last_update_submitted>
  <last_update_submitted_qc>October 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2012</last_update_posted>
  <responsible_party>
    <name_title>Karen Hartwell, M.D.</name_title>
    <organization>Medical University of South Carolina - Clinical Neuroscience Division</organization>
  </responsible_party>
  <keyword>nicotine</keyword>
  <keyword>addiction</keyword>
  <keyword>fMRI</keyword>
  <keyword>neuroimaging</keyword>
  <keyword>neurobiology</keyword>
  <keyword>craving</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

